Background and objective: Angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF) play a key role in the pathogenesis of preeclampsia. Uterine artery (UA) blood flow is important for preeclamptic pregnancy outcome, but small amount of evidence suggests UA dopplerometry for preeclampsia diagnostics and management. The aim of our study was to compare the value of angiogenic factors and UA dopplerometry in preeclampsia diagnosis and determine cut-off values to obtain the highest sensitivity and specificity of the parameter. Materials and methods: We performed a case controlled study of 72 pregnant women with preeclampsia and 72 healthy matched controls. SFlt-1 and PlGF were measured in serum sa...
Objective To investigate the maternal plasma concentration of soluble fms-like tyrosine kinase-1 (...
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers ha...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...
Background and objective: Angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt- 1) an...
Background: Hypertensive disorders like pre-eclampsia along with hemorrhage and infection, contribut...
Objectives: The objective of this study is to evaluate agreement between PlGF and sFlt-1/PlGF ratio ...
Women with hypertensive disorders in pregnancy: data on uterine arteries Doppler and biomarkers for ...
ObjectiveTo assess correlations between maternal serum levels of pro- and anti-angiogenic factors wi...
International audienceObjectives. - Despite its simple definition, preeclampsia can have variable an...
© Informa plcObjectiveCirculating angiogenic growth factors (such as vascular endothelial growth fac...
peer reviewedSoluble Fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in hi...
Preeclampsia (PE) is characterized by placental and maternal endothelial dysfunction, and associated...
Objective Preeclampsia (PE) is a complex and heterogeneous disorder of pregnancy. Current clinical d...
Objective: In preeclampsia, there will be an increase in SFlt-1 and in and decrease in PlGF levels. ...
The angiogenic factor ratio soluble Fms-kinase 1 (sFlt-1)/placental growth factor (PlGF) is a novel ...
Objective To investigate the maternal plasma concentration of soluble fms-like tyrosine kinase-1 (...
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers ha...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...
Background and objective: Angiogenic factors such as soluble fms-like tyrosine kinase 1 (sFlt- 1) an...
Background: Hypertensive disorders like pre-eclampsia along with hemorrhage and infection, contribut...
Objectives: The objective of this study is to evaluate agreement between PlGF and sFlt-1/PlGF ratio ...
Women with hypertensive disorders in pregnancy: data on uterine arteries Doppler and biomarkers for ...
ObjectiveTo assess correlations between maternal serum levels of pro- and anti-angiogenic factors wi...
International audienceObjectives. - Despite its simple definition, preeclampsia can have variable an...
© Informa plcObjectiveCirculating angiogenic growth factors (such as vascular endothelial growth fac...
peer reviewedSoluble Fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in hi...
Preeclampsia (PE) is characterized by placental and maternal endothelial dysfunction, and associated...
Objective Preeclampsia (PE) is a complex and heterogeneous disorder of pregnancy. Current clinical d...
Objective: In preeclampsia, there will be an increase in SFlt-1 and in and decrease in PlGF levels. ...
The angiogenic factor ratio soluble Fms-kinase 1 (sFlt-1)/placental growth factor (PlGF) is a novel ...
Objective To investigate the maternal plasma concentration of soluble fms-like tyrosine kinase-1 (...
Preeclampsia is a major cause of morbidity and mortality worldwide. Numerous candidate biomarkers ha...
Soluble fms-like tyrosine kinase 1 (sFlt-1) is an anti-angiogenic factor released in higher amounts ...